Schroder Investment Management Group Eagle Pharmaceuticals, Inc. Transaction History

Schroder Investment Management Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$37.02 - $51.28 $285,757 - $395,830	-7,719 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$43.24 - $55.02 $10.3 Million - $13.1 Million	-237,778 Reduced 96.86%	7,719 $370,000
Q1 2020 May 15, 2020	BUY	$34.37 - $60.07 $6.79 Million - $11.9 Million	197,592 Added 412.47%	245,497 $11.6 Million
Q4 2019 Feb 11, 2020	BUY	$54.32 - $64.31 $2.6 Million - $3.08 Million	47,905 New	47,905 $2.88 Million
Q4 2017 Feb 09, 2018	SELL	$49.6 - $60.87 $184,908 - $226,923	-3,728 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$46.62 - $60.36 $173,799 - $225,022	3,728	3,728 $219,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.